+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Age of Initiation and Patterns of Use among People Who Inject Drugs Welcomed in Harm Reduction Facilities in France from 2006 to 2015



Age of Initiation and Patterns of Use among People Who Inject Drugs Welcomed in Harm Reduction Facilities in France from 2006 to 2015



Journal of Psychoactive Drugs 2019: 1-12



This exploratory analysis of time-series cross-sectional data provides insights on trends in age at first injection among people who inject drugs in France, and on associations with recent risky injecting behaviors. Data were collected from a national survey conducted in harm reduction facilities in five phases between 2006 and 2015. Standardized questionnaires collected information on demographics, substance use, and route of administration, as well as lifetime and past-month injection. Descriptive and multilevel models were applied to account for the hierarchical structure of the data. Prevalence of lifetime and past-month injection remained stable over time, while the prevalence of daily injection increased significantly. Mean age at first injection only appeared to increase for data collected after 2010. Gender differences in mean age at first injection decreased over time, suggesting the development of converging patterns of initiation independent of sex. After controlling for covariates, early initiation of injection was unrelated to daily injection or material sharing, and associated with the number of recently injected substances. Early initiation is likely a predictor of injected polysubstance use. Findings are relevant to the planning, implementation, and evaluation of prevention programs.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 066446461

Download citation: RISBibTeXText

PMID: 30704351

DOI: 10.1080/02791072.2019.1567960


Related references

A pragmatic harm reduction approach to manage a large outbreak of wound botulism in people who inject drugs, Scotland 2015. Harm Reduction Journal 15(1): 36, 2018

Patterns of harm reduction service utilization and HIV incidence among people who inject drugs in Ukraine: A two-part latent profile analysis. International Journal on Drug Policy 43: 7-15, 2017

Effectiveness and cost-effectiveness of interventions targeting harm reduction and chronic hepatitis C cascade of care in people who inject drugs: The case of France. Journal of Viral Hepatitis 25(10): 1197-1207, 2018

Studies confirm effectiveness of harm reduction for people who inject drugs. Hiv/Aids Policy and Law Review 15(3): 29, 2012

Extremely low and sustained HIV incidence among people who inject drugs in a setting of harm reduction. Aids 28(2): 275-278, 2014

Reviewing harm reduction for people who inject drugs in Asia: the necessity for growth. Harm Reduction Journal 12: 32, 2016

Spore forming bacteria infections and people who inject drugs: Implications for harm reduction. International Journal on Drug Policy 53: 45-54, 2017

Venous access and care: harnessing pragmatics in harm reduction for people who inject drugs. Addiction 107(6): 1090-1096, 2012

Harm reduction interventions should encompass people who inject image and performance enhancing drugs. Bmj 353: I1889, 2016

Spore forming bacteria infections and people who inject drugs: Implications for harm reduction. International Journal of Drug Policy 53: 45-54, 2018

Changes in HIV incidence among people who inject drugs in Taiwan following introduction of a harm reduction program: a study of two cohorts. Plos Medicine 11(4): E1001625, 2014

Harm reduction-based and peer-supported hepatitis C treatment for people who inject drugs in Georgia. International Journal on Drug Policy 52: 16-19, 2017

Implementation of rapid HIV and HCV testing within harm reduction programmes for people who inject drugs: a pilot study. Aids Care 28(6): 712-716, 2016

Harm reduction-based and peer-supported hepatitis C treatment for people who inject drugs in Georgia. International Journal of Drug Policy 52: 16-19, 2018

Peering into the literature: A systematic review of the roles of people who inject drugs in harm reduction initiatives. Drug and Alcohol Dependence 151: 1-14, 2016